Vaccine for rare but deadly mosquito-born e viruses shows promise in clinical trial

Niaid.nih.gov

Click here to subscribe to Niaid.nih.gov

2 years ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

Vaccine for rare but deadly mosquito-borne viruses shows promise in clinical trial 05/12/2022 11:00 AM EDT
The injection was found to be safe, well-tolerated and induced a neutralizing antibody response in adult volunteers.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Share on

Other newsletters from Niaid.nih.gov

Funding news for global health researchers: November 25, 2024 Niaid.nih.gov
8 minutes ago
How the Current Continuing Resolu tion Impacts You and Your Project Niaid.nih.gov
19 minutes ago
Spotlight on Herbs and Other Botanicals Niaid.nih.gov
18 hours ago

More newsletters from Niaid.nih.gov

Vaccine for rare but deadly mosquito-born e viruses shows promise in clinical trial

Share on

Other newsletters from Niaid.nih.gov

Related newsletters